Variants in SLC6A1 were first identified in patients presenting MAE, which is characterized by a range of seizure types, including myoclonic, myoclonic-atonic, atonic and absence seizures [1,19]. The gene discussed is SLC6A1; the disease is Generalized non-motor (absence) seizure.